Free tool
FAERS Monitor: Adrenalin
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 204640 or its brand name (Adrenalin, Epinephrine). Reports on generic versions are filed under their own applications.
Reports
42,904
Serious
26,807
62% of reports
Hospitalization
14,202
Death reported
3,624
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- drug ineffective4,582
- headache3,085
- sinusitis2,921
- fatigue2,812
- product dose omission issue2,782
- pain2,498
- covid-192,425
- dyspnoea2,298
- nausea2,239
- off label use2,135
- pneumonia2,081
- inappropriate schedule of product administration1,786
- nasopharyngitis1,684
- pyrexia1,668
- urinary tract infection1,593
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 135 |
| 2005 | 118 |
| 2006 | 136 |
| 2007 | 166 |
| 2008 | 194 |
| 2009 | 275 |
| 2010 | 267 |
| 2011 | 706 |
| 2012 | 431 |
| 2013 | 342 |
| 2014 | 444 |
| 2015 | 673 |
| 2016 | 1,133 |
| 2017 | 1,654 |
| 2018 | 2,514 |
| 2019 | 3,369 |
| 2020 | 6,479 |
| 2021 | 3,953 |
| 2022 | 3,610 |
| 2023 | 3,814 |
| 2024 | 4,459 |
| 2025 | 4,762 |
| 2026 | 3,267 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,011,255 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| sinusitisSignal | 2,921 | 14.4 | 13.9 | 35,412 |
| covid-19Signal | 2,425 | 6.9 | 6.6 | 12,059 |
| inappropriate schedule of product administrationSignal | 1,786 | 4.9 | 4.7 | 5,527 |
| product dose omission issueSignal | 2,782 | 4.7 | 4.5 | 8,064 |
| urinary tract infectionSignal | 1,593 | 4.6 | 4.4 | 4,497 |
| nasopharyngitisSignal | 1,684 | 4.5 | 4.3 | 4,596 |
| pneumoniaSignal | 2,081 | 3.2 | 3.0 | 3,108 |
| headacheSignal | 3,085 | 2.4 | 2.3 | 2,633 |
| pyrexiaSignal | 1,668 | 2.4 | 2.3 | 1,335 |
| pain | 2,498 | 2.0 | 1.9 | 1,276 |
| dyspnoea | 2,298 | 2.0 | 1.9 | 1,165 |
| fatigue | 2,812 | 1.8 | 1.7 | 981 |
| drug ineffective | 4,582 | 1.7 | 1.7 | 1,425 |
| nausea | 2,239 | 1.4 | 1.3 | 251 |
| off label use | 2,135 | 1.2 | 1.1 | 71 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.